Observational study to evaluate the actual use of Dymista® nasal spray in different allergic rhinitis patient phenotypes

Study identification

• EU PAS number:
  EUPAS23075
• Study ID:
  34843
• Official title and acronym:
  Observational study to evaluate the actual use of Dymista® nasal spray in different allergic rhinitis patient phenotypes
• DARWIN EU® study:
  No
• Study countries:
  Austria

  Germany

  Hungary

  Ireland

  Netherlands
• Study description:
  The objective of this non-interventional study is gathering knowledge on patient phenotypes getting the same prescription for allergic treatment for the first time in routine clinical practice.
• Study status:
  Finalised

Research institutions and networks

Institutions

Multiple centres: 137 centres are involved in the study

Study timelines

Date when funding contract was signed

Actual: 10/03/2017

Study start date

Actual: 08/02/2018

Data analysis start date

Actual: 30/04/2019

Date of final study report

Actual: 20/09/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

MEDA Pharma GmbH & Co. KG

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable